Serum Hepcidin in the Athlete Clinical Workup: Why the Master Iron-Regulator Reads the Post-Exercise IL-6-Driven Iron-Absorption-Blockade Signal the Ferritin Trajectory Does Not See, the 3-to-6-Hour Peak-Response Window That Structures the Oral-Iron-Timing Protocol, the Alternate-Day Dosing Framework for the Chronic-Blockade Athlete, and the SOAP Structure That Carries the Finding Into the Dosing-Timing, Training-Session-Scheduling, and Repletion-Response Branches of the Plan
A 22-year-old female collegiate rower presents at week 6 of an 18-week spring-season base build with a ferritin that stalled at 18 ng/mL across a 10-week daily-ferrous-sulfate repletion trial the team physician initiated after a pre-season draw flagged a 15-ng/mL baseline. Every marker on the follow-up panel reads inside the laboratory reference bracket, no GI symptoms, no documented bleed, dietary intake adequate, vitamin-C co-ingestion confirmed. The repletion response has flat-lined, and the standard panel does not read the mechanism. The marker that does — serum hepcidin — reads the post-exercise IL-6-driven iron-absorption-blockade signal that the daily-dosing protocol is colliding with twice-per-day across the training-session calendar. This is the hepcidin interpretation guide for the sports RD: the IL-6-to-STAT3 biology that drives the 3-to-6-hour post-session hepcidin peak, the serum hepcidin reference-bracket and the post-exercise-trajectory reads that structure the oral-iron-timing decision, the alternate-day dosing framework that converts the flat-lined ferritin trajectory into a responsive-repletion trajectory, the four intake presentations that earn the ordered workup, and the SOAP structure that carries the finding into the dosing-timing, training-session-scheduling, and repletion-response branches of the plan.
A 22-year-old female NCAA Division I lightweight rower presents to the sports RD at week 6 of an 18-week spring-season base build toward the conference championship. The intake update carries the follow-up iron panel the team physician ordered against a 10-week trial of daily ferrous sulfate 65 mg elemental iron taken in the morning with orange juice. Pre-trial baseline (week minus-10): hemoglobin 12.9 g/dL, hematocrit 38.4 percent, MCV 88 fL, ferritin 15 ng/mL, serum iron 62 µg/dL, TSAT 18 percent, hs-CRP 0.9 mg/L. Current panel (week 6, 10 weeks into daily oral iron): hemoglobin 13.1 g/dL, hematocrit 39.0 percent, MCV 89 fL, ferritin 18 ng/mL, serum iron 68 µg/dL, TSAT 20 percent, hs-CRP 1.1 mg/L. The team-physician read on the follow-up panel returned "ferritin trending slowly upward, continue daily iron, repeat in eight weeks."
The read is defensible against the markers that were drawn. The problem is the trajectory. Ten weeks of daily elemental iron at 65 mg should move a 15-ng/mL ferritin into the 35-to-50-ng/mL bracket in a compliant athlete with intact gut absorption. The 3-ng/mL rise across ten weeks reads as a near-failure of absorption against the dose that was prescribed. The athlete is compliant (dosing log confirms missed-dose rate below 5 percent), reports no GI symptoms or constipation, confirms vitamin-C co-ingestion on every dose, denies NSAID exposure, denies PPI exposure, denies tea or coffee or calcium within two hours of the dose, and reports no menstrual-cycle irregularity, no documented GI blood loss, no documented hematuria, no dark-tinged urine. The dietary-recall read is adequate on the iron-and-vitamin-C intake. The iron is being swallowed. The iron is not reaching the plasma.
The marker that reads the absorption-blockade mechanism the standard panel does not capture — serum hepcidin — is the one marker the sports RD has to add to the next draw. Hepcidin is the master regulator of iron absorption at the duodenal enterocyte and iron recycling at the splenic and hepatic macrophage, and the trained-athlete population carries a documented post-exercise hepcidin elevation pattern that converts the daily-dosing oral-iron protocol into a twice-per-day collision between the swallowed dose and the training-session-driven absorption-blockade window. The read that separates the absorption-blockade mechanism from the compliance-failure or occult-loss differential — the serum hepcidin against the pre-session baseline and the 3-to-6-hour post-session peak — is a measurement the standard sports-medicine panel does not include and the oral-iron-repletion protocol the referring team physician initiated did not account for.
This is the serum hepcidin interpretation guide for the sports RD: the IL-6-to-STAT3 biology that drives the post-exercise hepcidin peak and the 3-to-6-hour window across which the duodenal enterocyte iron-absorption channel is closed, the reference-bracket and the post-exercise-trajectory reads that structure the oral-iron-timing decision, the alternate-day dosing framework that converts the flat-lined ferritin trajectory into a responsive-repletion trajectory, the four intake presentations that earn the ordered workup, and the SOAP structure that carries the finding into the dosing-timing, training-session-scheduling, and repletion-response branches of the plan.
The IL-6-to-STAT3 Biology That Drives the Post-Exercise Hepcidin Peak
Hepcidin is a 25-amino-acid peptide hormone synthesized by the hepatocyte and secreted into the plasma against two primary regulatory inputs: the iron-store signal (hepatic iron content, transferrin saturation, and the BMP-SMAD4-signaling axis that reads them) and the inflammatory signal (plasma interleukin-6 and the hepatic STAT3-signaling axis that transduces it). Circulating hepcidin binds the ferroportin iron-export channel on the basolateral membrane of the duodenal enterocyte, the splenic macrophage, and the hepatic Kupffer cell, triggering ferroportin internalization and proteasomal degradation. The downstream consequence is a closure of the plasma-facing iron-export route at the three tissues that collectively mediate approximately 95 percent of the daily iron flux into the plasma compartment: the duodenal absorption of dietary iron, the macrophage recycling of senescent erythrocyte iron, and the hepatocyte release of stored iron.
Exercise drives the inflammatory input. Sustained aerobic exercise above approximately 60 percent of VO2max for longer than 60 minutes generates a reliably measurable plasma IL-6 elevation across the duration of the session, peaking at or near session completion and clearing across the subsequent 2-to-4-hour window. The hepatic STAT3-signaling axis reads the IL-6 elevation and transduces it into a hepcidin transcriptional lift that reaches peak circulating concentration between 3 and 6 hours post-session, falls back toward the pre-session baseline across the subsequent 12-to-24-hour window, and clears to baseline by the following morning in the vast majority of healthy trained athletes. The magnitude of the peak is proportional to the duration-intensity product of the triggering session, with the strongest signal documented in the single-bout endurance-exercise exposure above 90 minutes and in the high-volume training weeks that aggregate multiple daily exposures without clearance between sessions.
The clinical consequence for the oral-iron-repletion protocol is direct. The duodenal enterocyte iron-absorption channel is closed across the 3-to-6-hour post-exercise window, closed again by any dose of oral iron within the preceding 24 hours (the iron-dose-driven hepcidin elevation is its own regulatory signal, independent of the exercise-driven signal), and closed persistently in the high-training-week athlete whose daily training-session calendar does not permit a clean 24-hour-hepcidin-clearance window between adjacent doses. The daily-dosing oral-iron protocol in the trained athlete collides with the post-exercise hepcidin peak at nearly every dose, blocks the absorption of the iron bolus at the duodenal channel, and generates the flat-lined ferritin trajectory the current-draw panel documents against a dose that would move the ferritin cleanly in an untrained population with intact 24-hour-hepcidin clearance.
The Serum Hepcidin Reference Bracket and the Post-Exercise Trajectory Read
Serum hepcidin is measured by competitive ELISA or mass-spectrometry immunoassay against a laboratory reference bracket that reads approximately 1 to 55 ng/mL in the general adult population, with the mean reading sitting near 10-to-15 ng/mL in the fasting-morning draw and the diurnal trajectory carrying a mid-day peak and an overnight nadir. The trained-athlete reference bracket shifts downward in the chronically-iron-restricted athlete (the hepcidin-suppression signal from the iron-store axis dominates the iron-restricted baseline) and shifts upward transiently across the 3-to-6-hour post-exercise window regardless of the baseline iron status.
The interpretive structure the sports RD applies against the reported value reads against three draw contexts.
Fasting pre-session baseline draw, 24 hours post the last training session. The clean-baseline read against the iron-store regulatory axis. The expected reading in the iron-restricted athlete with a ferritin below 30 ng/mL is a suppressed hepcidin against the lower end of the reference bracket, typically 1 to 5 ng/mL, reflecting the BMP-SMAD4 signaling response to the depleted iron stores and the compensatory down-regulation of hepcidin transcription that attempts to open the duodenal absorption channel against the deficit. A hepcidin reading inside or above the mid-reference-bracket band (above approximately 15 ng/mL) in an athlete with a ferritin below 30 ng/mL is inconsistent with the iron-restricted baseline and flags the secondary-hepcidin-elevation differential against a chronic-inflammatory signal (undocumented low-grade inflammation, subclinical infection, autoimmune activity, or the IL-6-driven training-load signal that has not cleared between daily sessions).
3-to-6-hour post-session draw on a scheduled moderate-to-high-duration-intensity session. The post-exercise peak-trajectory read. The expected reading in the iron-restricted athlete is a 2-to-4-fold rise against the fasting baseline, with the absolute reading typically landing in the 10-to-25-ng/mL band. A blunted or absent post-session rise flags the hepcidin-dysregulation pattern against an unresponsive IL-6-STAT3 axis and is uncommon in the asymptomatic trained-athlete presentation. An exaggerated rise above the 40-ng/mL band flags the amplified-inflammatory-response pattern against a potential heat-illness, viral-prodrome, or overtraining-syndrome differential and earns the paired hs-CRP, ESR, and CBC-with-differential read against the systemic-inflammation workup.
24-hour post-session draw on a scheduled moderate-to-high-duration-intensity session. The clearance-window read. The expected reading is a return to the fasting-pre-session baseline, with the 24-hour-post-session hepcidin reading matching the pre-session baseline within approximately a 2-ng/mL variance band. A persistent elevation above the pre-session baseline flags the incomplete-clearance pattern against the high-training-week daily-session calendar and is the single most actionable finding for the oral-iron-dosing-timing protocol — the daily-dosing schedule is colliding with a 24-hour-persistent hepcidin-elevation signal that blocks absorption at every dose, and the alternate-day dosing protocol or the morning-session-plus-pre-session-dose protocol is the structural correction.
The Alternate-Day Dosing Framework
The alternate-day oral-iron-dosing protocol is the primary structural correction the sports RD coordinates with the referring team physician against the flat-lined ferritin trajectory in the trained-athlete oral-iron-repletion case. The mechanism is direct: the hepcidin elevation driven by the iron dose itself persists for approximately 24 hours, the exercise-driven hepcidin elevation persists for approximately 12 to 24 hours against a moderate-to-high-duration session, and the daily-dosing schedule generates a chronic hepcidin-elevated state that blocks the absorption of the subsequent dose at the duodenal channel. The alternate-day dosing schedule inserts a 48-hour dose-to-dose window that allows the hepcidin to clear between doses and opens the duodenal absorption channel across the dosing day.
The empirical evidence for the alternate-day protocol in the general population reads a 25-to-50 percent increase in cumulative iron absorption across a two-week dosing window against the daily-dosing comparator, with the signal replicated in both the healthy-iron-deficient and the post-bariatric-surgery populations. The trained-athlete population carries the additional post-exercise hepcidin-peak signal that compounds the daily-dosing absorption-blockade problem, and the alternate-day protocol in the trained athlete is scheduled against the training-session calendar to position each dose on a morning following a scheduled off-day or a scheduled light-recovery session, with the next dose 48 hours later again scheduled against a low-hepcidin window.
The practical scheduling framework reads: Monday-Wednesday-Friday dosing against a Sunday-Tuesday-Thursday off-or-recovery schedule, or Tuesday-Thursday-Saturday dosing against a Monday-Wednesday-Friday off-or-recovery schedule, with the dose taken on waking with 500 mg vitamin C and no coffee, tea, calcium supplement, or calcium-fortified food in the subsequent two-hour window. The elemental-iron dose per dosing day is increased against the daily-dose target to maintain the weekly cumulative dose at or above the pre-alternate-day target (a shift from daily 65 mg elemental to alternate-day 130 mg elemental maintains the weekly cumulative at 455 mg against the previous 455 mg daily-dose weekly cumulative), with the tolerability window monitored against the paired constipation, nausea, and epigastric-discomfort checklist.
The serial-ferritin tracking cadence against the alternate-day protocol reads an 8-week post-initiation redraw to confirm the trajectory response, with the expected movement in the responsive athlete reading a 10-to-20-ng/mL ferritin lift across the 8-week window against the 3-ng/mL-per-10-week lift the daily-dosing protocol generated. Non-responders to the alternate-day protocol earn the paired serum-hepcidin draw at 8 weeks against the baseline to confirm the clearance-window response and the paired-marker workup against the alternative absorption-blockade differential (H. pylori, atrophic gastritis, celiac disease, chronic PPI exposure, undocumented low-grade inflammation).
The Four Intake Presentations That Earn the Ordered Workup
Any athlete on a documented oral-iron-repletion protocol whose ferritin trajectory has flat-lined across a 6-to-10-week trial against a dose-and-compliance combination that should move the trajectory. The serum hepcidin draw against the pre-session baseline and the 24-hour post-session clearance window reads the absorption-blockade mechanism against the compliance-failure or occult-loss differential and structures the alternate-day-dosing correction against the identified pattern.
Any trained endurance athlete entering a high-volume training block (greater than 10 hours per week aggregate session duration, greater than 5 session-days per week) with a baseline ferritin below 30 ng/mL. The baseline serum hepcidin against the fasting draw anchors the pre-block iron-absorption-channel read and structures the oral-iron-prophylaxis-dosing-timing protocol against the training-session calendar before the ferritin-trajectory stall pattern develops.
Any athlete with a documented repletion failure across two separate oral-iron protocols (daily and alternate-day) against adequate compliance and adequate paired-marker reads. The paired serum hepcidin and the paired-absorption-blockade workup (H. pylori antibody, tissue transglutaminase antibody with total IgA, fasting gastrin against the PPI-exposure history, urinary ferritin against the hemolytic-pattern differential) structures the escalation decision toward the intravenous iron referral against the oral-iron-refractory differential.
Any athlete presenting with a documented concurrent inflammatory signal (hs-CRP persistently above 3 mg/L across two serial draws, ESR persistently elevated, autoimmune-disease diagnosis, inflammatory-bowel-disease diagnosis) against an iron-restricted baseline ferritin. The serum hepcidin draw separates the anemia-of-inflammation pattern (hepcidin elevated against the IL-6-driven STAT3-axis signal regardless of iron-store status) from the pure iron-deficiency pattern (hepcidin suppressed against the BMP-SMAD4-axis signal from the depleted stores) and structures the oral-iron-versus-iv-iron decision against the correct mechanism.
The SOAP Documentation
My structure on the presenting rower vignette reads: "Twenty-two-year-old female NCAA Division I lightweight rower, week 6 of an 18-week spring-season base build at 14 hours weekly aggregate session volume across six session-days per week, pre-trial baseline iron panel ferritin 15 ng/mL with normal CBC, 10-week trial of daily ferrous sulfate 65 mg elemental iron with confirmed compliance (dosing log missed-dose rate below 5 percent) and confirmed 500-mg vitamin-C co-ingestion with each dose, follow-up panel ferritin 18 ng/mL (3-ng/mL lift across 10-week trial against expected 20-to-35-ng/mL lift), no GI symptoms, no documented bleed, no NSAID or PPI exposure, menstrual cycle regular, dietary recall adequate on iron and vitamin C. Draws ordered today: fasting pre-session serum hepcidin on a Monday morning scheduled off-day with no training session in the preceding 24 hours; 3-to-6-hour post-session serum hepcidin on a scheduled Tuesday 90-minute steady-state row with the draw timed against the session completion; 24-hour post-session serum hepcidin on the Wednesday morning following the Tuesday session; paired hs-CRP, ESR, CBC-with-differential, tissue transglutaminase IgA with total IgA, H. pylori stool antigen, fasting gastrin against the undocumented-PPI-exposure differential, urinary ferritin against the occult-hemolytic-pattern differential, and a repeat ferritin and TSAT against the current-draw baseline. Expected turnaround 5 to 7 business days. Working rationale: the 3-ng/mL ferritin lift across a 10-week daily-dosing oral-iron trial in a compliant athlete with intact gut-absorption markers and adequate dietary co-ingestion is inconsistent with the expected repletion trajectory and consistent with the post-exercise-hepcidin-driven absorption-blockade pattern the trained-athlete oral-iron-repletion literature documents against the high-volume training-week calendar, the fasting-pre-session hepcidin read against the iron-restricted baseline separates the BMP-SMAD4-axis-suppressed-baseline pattern (hepcidin below 5 ng/mL, confirms the pure iron-deficiency read and anchors the alternate-day-dosing correction) from the inflammation-driven-elevated-baseline pattern (hepcidin above 15 ng/mL, flags the chronic-inflammatory-signal workup against the hs-CRP/ESR/autoimmune differential), the 3-to-6-hour post-session hepcidin confirms the post-exercise-peak trajectory against the training-session-exposure, and the 24-hour post-session hepcidin confirms the clearance-window response against the alternate-day-dosing-protocol scheduling decision. Plan: panel returning next week; if fasting hepcidin reads suppressed (below 5 ng/mL) against confirmed post-exercise peak with 24-hour clearance, pure iron-deficiency pattern confirmed and alternate-day dosing initiated at 130 mg elemental iron per dosing day on Monday-Wednesday-Friday schedule against the Sunday-Tuesday-Thursday off-or-light-recovery day structure with the dose taken on waking with 500 mg vitamin C and a two-hour abstention from coffee, tea, calcium supplement, or calcium-fortified food; if fasting hepcidin reads elevated against the inflammation-driven baseline, oral-iron protocol held pending the paired hs-CRP/ESR/autoimmune-differential workup and the inflammation-source identification; if the 24-hour post-session hepcidin reads persistently above the pre-session baseline, the high-training-week daily-exposure pattern is confirmed and the alternate-day dosing schedule is anchored against the explicit 48-hour low-hepcidin window between doses; if the paired-marker workup returns a positive H. pylori, celiac, PPI-exposure, or chronic-inflammatory signal, oral-iron protocol held pending the target-mechanism treatment and the iv-iron-referral decision made against the oral-iron-refractory differential at the 16-week post-correction redraw if the ferritin trajectory remains flat. Serial ferritin cadence set at 8-week post-protocol-change redraw against the alternate-day-dosing-initiation date, with the paired hepcidin re-measured at the 8-week redraw to confirm the clearance-response against the schedule."
The assessment line names the pattern as "daily-oral-iron-dosing-refractory ferritin stall at 18 ng/mL in a high-training-week trained endurance athlete consistent with the post-exercise-hepcidin-driven duodenal-absorption-blockade pattern pending fasting-pre-session, 3-to-6-hour post-session, and 24-hour post-session serum hepcidin triplicate measurement against the training-session-exposure calendar and the paired-absorption-blockade-differential workup" rather than "iron-deficiency anemia with slow response to oral iron — continue current protocol." The plan line specifies the triplicate hepcidin measurement as the mechanism-clarification instrument that gates the alternate-day-dosing-protocol-versus-iv-iron-referral decision, the paired-absorption-blockade-differential workup as the parallel-mechanism-closure instrument, and the training-session-calendar-anchored dosing-timing protocol as the structural correction that opens on day one against the correct interpretation.
The Follow-Up Cadence
Ferritin and TSAT redraw at 8 weeks post-alternate-day-protocol-initiation. The 8-week redraw confirms the trajectory response against the expected 10-to-20-ng/mL lift and anchors the longitudinal file against the correct dosing-protocol baseline. The serial redraw at the 16-week window against a confirmed-responsive trajectory closes the acute-repletion phase and transitions the athlete to the maintenance-dosing protocol anchored against the pre-season and post-season annual ferritin draws.
Paired serum hepcidin redraw at 8 weeks post-alternate-day-protocol-initiation. The 8-week paired hepcidin against the baseline confirms the clearance-window response against the schedule and reads the sustained alternate-day-dosing absorption-channel-opening signal against the previous daily-dosing persistent-elevation pattern.
Paired-marker workup redraw against the identified absorption-blockade signal at the 4-to-6-week post-target-mechanism-treatment window. The H. pylori eradication confirmation, the celiac serology post-gluten-free-trial read, the PPI-exposure-discontinuation read, and the chronic-inflammatory-signal workup redraw structure the absorption-channel-restoration confirmation before the oral-iron-repletion protocol restarts.
IV iron referral at any athlete with a confirmed oral-iron-refractory pattern (flat-lined ferritin trajectory across the alternate-day-dosing 16-week window with confirmed clearance-window hepcidin response and negative paired-absorption-blockade-differential workup), any athlete with a documented severe iron deficiency at pre-season baseline (ferritin below 10 ng/mL with symptomatic presentation), or any athlete entering a competition-season window with insufficient repletion time against the oral-iron-dosing timeline. The referral opens the iv-iron-dosing pathway at the correct severity threshold against the broader iv-iron-dosing-protocol framework the sports RD coordinates with the referring sports-medicine team.
Where Calsanova Fits
The serum hepcidin interpretation workflow depends on the intake carrying the training-session-calendar capture that structures the pre-draw exposure window, the oral-iron-repletion-protocol capture that tracks the dosing schedule, compliance log, co-ingestion log, and cumulative-dose trajectory against the ferritin-response timeline, the triplicate-hepcidin-measurement scheduling framework pre-populated against the training-session-calendar, the alternate-day-dosing-protocol decision tree that reads the fasting-baseline-plus-clearance-window hepcidin response against the schedule-correction decision, the paired-absorption-blockade-differential ordering framework that reads the H. pylori, celiac, gastrin, and inflammatory-signal workup against the oral-iron-refractory pattern, the SOAP template pre-populated against the mechanism-driven differential and the dosing-timing-plus-schedule-correction intervention plan, and the longitudinal file that anchors the career-arc iron-status trajectory across the pre-season, mid-season, and post-season draws paired against the training-load trajectory. Calsanova's clinical intake carries the training-session-calendar capture that triggers the hepcidin-triplicate-measurement scheduling on any flat-lined oral-iron-repletion case, the oral-iron-dosing-log capture with the compliance, co-ingestion, and cumulative-dose tracking against the paired ferritin trajectory, the hepcidin-trajectory interpretive module that reads the triplicate measurement against the fasting-baseline, post-session-peak, and 24-hour-clearance brackets with reference-threshold flagging and the schedule-correction annotation, the alternate-day-dosing-protocol decision-tree module pre-populated against the training-session-calendar, the SOAP template pre-populated against the mechanism-driven differential and the dosing-timing-plus-schedule-correction intervention plan, the longitudinal ferritin-and-hepcidin file that tracks the iron-status trajectory against the training-load trajectory across the career arc, and the iv-iron-referral workflow that opens at the correct severity threshold with the triplicate-hepcidin context and the paired-absorption-blockade-differential workup pre-attached to the referring communication.
Ready to move your sports-nutrition clinical workflow into a purpose-built system? [Try Calsanova free for 30 days](/signup?role=dietitian) — no credit card, HIPAA-ready from day one, and the serum hepcidin interpretation workup runs cleanly against the training-session-calendar capture, the oral-iron-dosing-log tracking, the triplicate-hepcidin-measurement scheduling framework, the alternate-day-dosing-protocol decision tree, the paired-absorption-blockade-differential ordering framework, the SOAP template, and the longitudinal file that catches the real iron-deficiency-refractory pattern while anchoring the dosing-timing correction that converts the flat-lined ferritin trajectory into a responsive-repletion trajectory against the training-session-exposure reality.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
IGF-1 and IGFBP-3 in the Athlete Clinical Workup: Why the Spot IGF-1 Alone Misses the Hepatic GH-Resistance Signature of Low Energy Availability, the Computed Molar Ratio That Reads the Ternary-Complex Biology, the Four Paired-Draw Patterns That Classify the GH-IGF-1 Axis, and the SOAP Structure That Carries the Finding Into the Energy-Availability, Training-Load, and Sports-Endocrinology-Referral Branches of the Plan
A 20-year-old female NCAA Division I distance swimmer presents at week 14 of a 22-week championship build with a six-week plateau on her 200-meter freestyle splits, a 1.2-kilogram loss of DXA-measured fat-free mass, a luteal-phase deficiency on a four-month basal-body-temperature chart, a 24-hour recall log at 2,100 kcal against an estimated 2,750-kcal need, and a team-physician-ordered IGF-1 that returned 215 ng/mL. The laboratory report flags the value as within the age-decade reference bracket and the ordering physician's chart note reads IGF-1 normal, no further endocrine workup indicated. The spot IGF-1 reads the panel as reassuring. The integrated growth-hormone-IGF-axis signal that is actually driving the plateau is not readable from the IGF-1 alone. The marker that reads the hepatic GH-resistance signature against the dominant binding-protein pool, insulin-like growth factor binding protein 3 (IGFBP-3), and the computed IGF-1/IGFBP-3 molar ratio that reads against the ternary-complex biology are the two reads the sports RD has to add to the next panel. This is the paired IGF-1 plus IGFBP-3 interpretation guide for the sports RD: the GH-receptor-to-JAK2-STAT5 biology that drives the dissociated storage-versus-synthesis signal, the age-decade reference brackets, the four paired-draw patterns that classify the GH-IGF-1 axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the free-T3-and-gonadal-axis RED-S differential, the SOAP structure that carries the finding into the energy-availability, training-load, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 19, 2026
1,25-Dihydroxyvitamin D vs 25-Hydroxyvitamin D in the Athlete Clinical Workup: Why the Active-Form Assay Reads the Calcium-Demand-Driven Up-Regulation the Storage-Form Trajectory Does Not See, the Four Paired-Draw Patterns That Classify the Vitamin D Endocrine Axis, the Four Athlete-Population Presentations That Earn the Ordered Paired Draw, and the SOAP Structure That Carries the Finding Into the Dietary, Bone-Health, and Sports-Endocrinology-Referral Branches of the Plan
A 28-year-old female collegiate cross-country runner at week 11 of a 16-week outdoor track build presents with a four-week plateau on her 5k pace, muscle soreness extending into day three after her hard sessions, a 24-hour recall log at 1,800 kcal against an estimated 2,400 kcal need, a cycle gap at eight weeks, and a 25-hydroxyvitamin D of 42 ng/mL drawn at her annual physical. The storage-form vitamin D reads replete against both the Endocrine Society and Institute of Medicine reference brackets. The clinician reads the panel as vitamin D sufficient. The persistent symptom complex, the cycle disruption, and the low-energy-availability pattern on the log tell the sports RD the vitamin D endocrine axis is not readable from the 25-OH-D alone. The marker that reads the calcium-demand-driven activation of the renal 1-alpha-hydroxylase — 1,25-dihydroxyvitamin D, calcitriol, the active hormonal form — is the one the sports RD pairs with the storage marker on the next draw. This is the paired 25-OH-D plus 1,25-DH-D interpretation guide for the sports RD: the storage-vs-hormone biology that drives the dissociated read, the Endocrine Society and active-form reference brackets, the four paired-draw patterns that classify the vitamin D endocrine axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the calcium-phosphate-PTH-FGF-23 axis, the SOAP structure that carries the finding into the dietary, bone-health, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 17, 2026
DHEA-S in the Athlete Clinical Workup: Why the Long-Half-Life Adrenal Androgen Reads the Integrated HPA-Axis Burden That the Spot Cortisol Does Not See, the Cortisol-to-DHEA-S Ratio That Separates Functional Overreaching From Non-Functional Overtraining, the Four Athlete-Population Presentations That Earn the Ordered Draw, and the SOAP Structure That Carries the Finding Into the Training-Load, Recovery-Window, and Sports-Endocrinology-Referral Branches of the Plan
A 24-year-old male collegiate 1500-meter runner presents at week 14 of a 20-week championship build with a six-week plateau on his 800-meter repeat splits, a resting heart rate drift of 8 bpm above his 14-day baseline on a Whoop morning read, a sleep-efficiency drift from 91 to 83 percent, a Profile-of-Mood-States score inside the elevated-fatigue bracket, and a morning salivary cortisol the sports-medicine physician drew two weeks earlier that returned 14.2 nmol/L — inside the laboratory reference bracket. The spot cortisol reads the panel as normal. The integrated HPA-axis burden that is actually driving the plateau is not readable on the spot cortisol. The marker that reads the eight-to-ten-hour integrated adrenal pool — dehydroepiandrosterone sulfate, the long-half-life adrenal androgen — is the one the sports RD has to add to the next panel. This is the DHEA-S interpretation guide for the sports RD: the zona-reticularis biology that drives the stable-pool read, the reference bracket by sex and age decade, the cortisol-to-DHEA-S ratio that separates adaptive HPA drive from maladaptive HPA suppression, the four athlete-population presentations that earn the ordered draw, the SOAP structure that carries the finding into the training-load, recovery-window, and sports-endocrinology-referral branches of the plan, and the six-to-eight-week follow-on redraw cadence that tracks the recovery trajectory against the taper or deload prescription.
November 12, 2026